論文（2024）

著書

1 中島千穂、荒金尚子　ドライバー遺伝子変異とコンパニオン診断薬 日本医師会雑誌 第153巻・特別号(2)　生涯教育シリーズ 107 呼吸器疾患ペディア Ⅱ章 78-81 2024,10 日本医師会.東京 ISSN:0021-4493

 

原著論文

1　Hidaka M, Inokuchi K, Uoshima N, Takahashi N, Yoshida N, Ota S, Nakamae H, Iwasaki H, Watanabe K, Kosaka Y, Komatsu N, Meguro K, Najima Y, Eto T, Kondo T, Kimura S, Yoshida C, Ishikawa Y, Sawa M, Hata T, Horibe K, Iida H, Shimomura T, Dobashi N, Sugiura I, Makiyama J, Miyagawa N, Sato A, Ito R, Matsumura I, Kanakura Y, Naoe T Development and evaluation of a rapid one‑step high sensitivity real‑time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) Jpn J Clin Ooncol, 54(2): 153-159 2024

2　Kubo T, Matsuo S, Sogawa R, Yasu T, Nagaie T, OkamotoS, Kimura S, Shimanoe C Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administration Int J Clin Pharm Th, 62(1):56-60 2024

3　Han HJ, Kim JJ, Pyne D, Travas A, Ambalavanan A, Kimura S, Deininger MW, Kim JW, Kim DD  In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile Leukemia, 38(2): 412-41 2024

4　Yazdanpanah N, Sedikides C, Ochs HD, Camargo CA Jr, Darmstadt GL, Cerda A, Cauda V, Peters GJ, Sellke F, Wong ND, Comini E, Jimeno AR, Glover V, Hatziargyriou N, Vincenot CE, Bordas SPA, Rao IM, Abolhassani H, Gharehpetian GB, Weiskirchen R, Gupta M, Chandel SS, Olusanya BO, Cheson B, Pomponio A, Tanzer M, Myles PS, Ma WX, Bella F, Ghavami S, Moein Moghimi S, Pratico D, Hernandez AM, Martinez-Urbistondo M, Urbistondo DM, Fereshtehnejad SM, Ali I, Kimura S, Wallace Hayes A, Cai W, Ernest CKJ, Thomas S, Rahimi K, Sorooshian A, Schreiber M, Kato K, Luong JHT, Pluchino S, Lozano AM, Seymour JF, Kosik KS, Hofmann SG, McIntyre RS, Perc M, Leemans A, Klein RS, Ogino S, Wlezien C, Perry G, Nieto JJ, Levin L, Klionsky DJ, Mobasher B, Dorigo T, Rezaei N Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic  Adv Exp Med Biol 1457:1-31 2024

5　Ureshino H, Ueda Y, Fujisawa S, Usuki K, Tanaka H, Okada M, Kowada S, Murai K, Hirose A, Shindo M, Kumagai T, Takeoka T, Kamachi K, Kidoguchi K, Shindo T, Iama S, Inamura J, Nakao T, Kobayashi T, Kawata E, Ohkawara H. Ikezoe T, Kawaguchi A, Kimura S KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC Trial, a Multicentre Observational Study Blood neoplasia, 1 (1): 1-8 2024

6　Watanabe T, Yamamoto Y, Kurahashi Y, Kawazoe K, Kidoguchi K, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Nakamura H, Okada S, Sueoka E, Kimura S.  Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells Blood Adv, 8(6): 1345-1358 2024

7　Yamamoto Y, Watanabe T, Kurahashi Y, Ureshino H, Fukuda-Kurahashi Y, Kawasoe K, Kidoguchi K, Yamashita S, Hattori N, Kamachi K, Ushijima T, Kimura S DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis Leukemia, 38(7): 1613-1616 2024
Ureshino H, Takeda Y, Kamachi K, Ono T, Iriyama N, Ohtsuka E, Sakaida E, Kimura S.  Higher neutrophil count is associated with favorable achievement of treatment-free remission in patients with chronic myeloid leukemia who received second generation tyrosine kinase inhibitor as frontline treatment Clin Pract, 14(4):1216-1224 2024

8　Ureshino H, Takahashi N, Ikezoe T, Kameoka Y, Kimura S, Fukushima N, Ichinohe T, Takamori A, Kawaguchi A, Miura M, Kimura S A lower initiating dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: A single-arm, multicenter, Phase 2 trial (BOGI trial) Int J Hematol,120(4):492-500 2024

9　Yamada M, Nakao M, Yamada N, Nakamura H, Itoh M, Yunoki M, Kamohara K, Kimura S, Sueoka E. Immune cell kinetics after allogeneic red blood cell transfusion in patients undergoing cardiovascular surgery. Running title: Immune Response in Allogeneic Red Blood Cell Transfusions Transfus Clin Biol. 31(4):223-228Immune cell kinetics after allogeneic red blood cell transfusion in patients undergoing cardiovascular surgery. Running title: Immune Response in Allogeneic Red Blood Cell Transfusions Transfus Clin Biol. 31(4):223-228 2024

10　Kusaba K, Watanabe T, Kidoguchi K, Yamamoto Y, Tomoda A, Hoshiko T, Kojima N, Nakata S, Kimura S.  Targeting oxidative phosphorylation with a novel thiophene carboxamide increases the efficacy of imatinib against leukemic stem cells in chronic myeloid leukemia Int J Mol Sci, 25(20):11093-11104 2024

11　Moriguchi M, Nakamae H, Nishimoto M, Sugita J, Yanada M, Toubai T, Hasegawa Y, Hino M, Nishida T, Kurita N, Sawa M, Fukuda T, Jinguji A, Ota S, Matsuoka KI, Eto T, Hiramoto N, Ando T, Kawamura K, Kanda Y, Atsuta Y, Ohbiki M, Nakasone H, Konuma T. Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemia Br J Haematol. 205(6):2376-2386. 2024

12　Ido K, Nakamae H, Hattori N, Kanaya M, Morita K, Hino M, Ohigashi H, Fukuda T, Eto T, Nagafuji K, Hiramoto N, Maruyama Y, Ota S, Matsuoka KI, Ando T, Akasaka T, Mori Y, Kamimura T, Kawakita T, Kawamura K, Kanda J, Onizuka M, Atsuta Y, Murata M. Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide Br J Haematol. 205(3):1077-1096. 2024

13　Furuno T, Sogawa R, Hashimoto T, Matsuo S, Shirahama W, Kamura T, Hosoya K, Senjyu Y, Yamashita Y, Inoue T, Yamauchi M, Katsuya H, Noguchi M, Sueoka-Aragane N, Shimanoe C. Association between the Prognostic Nutritional Index and the Occurrence of Immune-Related Adverse Events. Biol Pharm Bull.;47(2):361-365. 2024

14　Kito Y, Kawakami H, Mitani S, Nishina S, Matsumoto T, Tsuzuki T, Shinohara Y, Shimokawa H, Kumanishi R, Ohta T, Katsuya H, Kawakami T, Nishina T, Hasegawa H, Akiyoshi K, Chiba Y, Yamazaki K, Hironaka S, Muro K. Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G) Oncologist.;29(3):e330-e336. 2024

15　Maida S , Nakagawa H, Ureshino H, Kajihara K, Yamazaki S, Ichinohe T Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute Blood Cells Mol.108:102870  2024

16　Ureshino H, Kamachi K, Kidoguchi K, Kimura S  IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP.
eJHaem.5(6):1278-1282

17　Shimada K,Ohmachi K,Machida R,Ota S,Itamura H,Tsujimura H,Takayama N,Shimada T,Kurosawa M,Tabayashi T,Shimoyama T,Ohshima K,Miyazaki K,Maruyama D,Kinoshita T,Ando K, Hotta T, Tsukasaki K, Nagai H Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601 Ann Hematol. 2024 Jun;103(6):2021-2031. 2024


18　Kiritani A, Amino Y, Uchibori K, Akita T, Harutani Y, Ogusu S, Tsugitomi R, Manabe R, Ariyasu R, Kitazono S, Yanagitani N, Nishio M. Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion. Thorac Cancer. 2024 Feb;15(5):402-409.  2024,2

19　Matsuyama T, Tanaka J, Tone K, Shimizu K, Nakano T, Takahashi K. THE EFFICACY OF BRONCHIAL THERMOPLASTY IN LONG-TERM MAINTENANCE OF ADULT PATIENTS WITH MODERATE TO SEVERE ASTHMA Arerugi. 2024;73(1):40-51.  2024,2

20　Kurihara Y, Tashiro H, Konomi Y, Sadamatsu H, Ihara S, Takamori A, Kimura S, Sueoka-Aragane N, Takahashi K Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice Allergol Int. 2024 Apr;73(2):313-322. 2024,4

21　Masaki K, Sakashita M, Ogawa Y, Inomata T, Kainuma K, Kan-O K, Sato S, Tamari M, Nakajima S, Morita H, Kurashima Y, Futamura M, Takahashi K, Haruta J, Hyakutake M, Monkawa T, Ishizuka T, Imoto Y, Oyama N, Kanzaki S, Kidoguchi M, Fukushima A, Fukunaga K, Fujieda S, Yasutomi M, Adachi T. RECURRENT AND VIRTUAL EDUCATION FOR ALL DISCIPLINES AND OCCUPATIONS IN THE ALLERGY REALM : A SURVEY OF THE PARTICIPANTS FROM THE INITIATIVE 'OUTREACH LECTURES' TO CREATE EDUCATIONAL OPPORTUNITIES Arerugi. 2024;73(4):329-339 2024,6

22　Kuroki Y, Takamori A, Takahashi K, Yamamoto S, Yoshida N, Enaida H. Survey on Findings and Utilization of Preoperative Chest Radiography in Ophthalmic Surgery J Clin Med. 2024 Jul 3;13(13):3909. 2024,7

23　Tanaka H, Makiguchi T, Tozuka T, Kawashima Y, Oba T, Tsugitomi R, Koyama J, Tambo Y, Ogusu S, Saiki M, Gyotoku H, Hasegawa T, Miyauchi E, Sonoda T, Saito R, Nakatomi K, Sakatani T, Kudo K, Tsuchiya-Kawano Y, Nishio M. Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49 %): TOPGAN2023-01. Eur J Cancer. 2024 Dec;213:115117. 2024,12

24　Takahashi K, Makita N, Castañeda-Sanabria J, Argoubi R, Nowacki G, Issa S, Matsumoto I, Yoshida Y, Müllerová H. Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan: A Real-World Healthcare Claims Database Study (MITOS-AURA) Adv Ther. 2024 Dec;41(12):4518-4536. 2024,12

 

総説

1　Ureshino H, Kamachi K, Kimura S.  Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia Clin Lymphoma Myeloma Leuk, 24(4):　e138-141 2024

2　Morimoto T, Toda Y, Hakozaki M, Paholpak P, Watanabe K, Kato K, Tsukamoto M, Hirata H, Kaneuchi Y, Tome Y, Nagamine S, Nishida K, Katsuya H, Matsumoto Y, Otani K, Mawatari M, Nikaido T. A new era in the management of spinal metastasis. Front Oncol. 2024 Apr 16;14:1374915. 2024

3　Ureshino H,  Kimura S. Efficacy and Safety of the First-in-Class STAMP-Inhibitor Asciminib in Patients With Chronic Myeloid Leukemia Clin Lymphoma Myeloma Leuk, 25(1):e57-e61. 2025

4　岡本　翔 白血性マクログロブリン血症 別冊日本臨牀 領域別症候群シリーズ No.30 血液症候群(第 3 版) V ―その他の血液疾患を含めて―, 76-80 2024年3月

5　Tatsuro Watanabe, Keisuke Kidoguchi , Shinya Kimura  Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine Cancer Sci 2025; Jan 21. Online ohead of print. 2025年1月

6　Tashiro H, Kurihara Y, Kuwahara Y, Takahashi K. 1 Impact of obesity in asthma: Possible future therapies. Allergol Int. 2024 Jan;73(1):48-57.  2024,1

7　高橋浩一郎  治療法の再整理とアップデートのために専門家による私の治療「気胸」 日本医事新報、5213巻、43頁 2024,3

8　栗原有紀、田代宏樹、髙橋浩一郎  気管支喘息の病態と臨床的寛解を目指した治療 臨床免疫・アレルギー科、81巻、4号、320－326 2024,4

9　高橋浩一郎  新ガイドラインが提示する安定期COPD気管支拡張療法（気管支拡張薬） 日本医事新報、5253巻、54頁 2024,12

10　桑原雄紀、髙橋浩一郎 2 喘息・COPD患者の指導～高齢者指導のポイント～ medicina、第61巻、13号、2365-2369頁 2024,12

 

症例報告

1　Inayoshi S, Inoue T, Katsuya H, Sugita K. Chronic actinic dermatitis as a diagnostic clue for adult T-cell leukemia/lymphoma JAAD Case Rep.;55:10-12. 2024

2　Doi-Fujita A, Edahiro T, Ureshino H, Yoshida T,  Ichinohe T Facial nerve palsy and hypopituitarism associated with immunoglobulin G4-related disease in an elderly man Am J Med Sci. 367(3):e35-e36. 2024

3　Edahiro T, Ureshino H, Nakamori M, Shindo T, Ichinohe T. Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral Neuropathy. Cureus. 16(11):e74703. 2024

4　Kisu E, Hiraki M, Okuyama K, Maeda S, Takesue S, Kusaba K, Kai K, Manabe T, Noshiro H. Multiple foci of Rosai-Dorfman disease in colon: a case report Surg Case Rep. 2024 Jul 19;10(1):173. 2024

5　Nakashima C, Kuwahara Y, Kitamura S, Kai K, Hiratsuka M, Kajiwara K, Komiya N, Ogusu S, Kimura S, Sueoka-Aragane N. Advanced non-small cell lung cancer patient with a complete response and allergic immune-related adverse events by combined immunotherapy, including anti-CTLA-4 and anti-PD-1 antibodies: A case report Current Problems in Cancer: Case Reports; 2024;14: 100298 2024,6

6　南里水晶, 田代宏樹, 梶原　心, 桑原雄紀, 栗原有紀　, 小宮奈津子, 小楠真典, 中島千穂, 髙橋浩一郎　 肺外結核と診断された同施設内ネパール人の 2 例Kekkaku Vol. 99, No. 7 : 201-204, 2024 2024,11

7　Kuwahara Y, Tashiro H, Takeshita G, Egashira Y, Maruyama A, Ikeda Y, Kimura S, Sueoka-Aragane N, Takahashi K Refractory bilateral chylothorax and chylous ascites in a patient with systemic lupus erythematosus treated by pleuro-peritoneal and peritoneal-venous shunts along with cell-free and concentrated ascites re-infusion therapy Respir Investig. 2024 Nov;62(6):1191-1194 2024,11

8　Tashiro H, Nanri M, Kuwahara Y, Kurihara Y, Kimura S, Takahashi K Possible Biological Heterogeneity of Airway Mucus Plugs in a Patient with Asthma J Asthma Allergy. 2024 Dec 8:17:1265-1269. 2024,12

 

最終更新日　2025年12月29日

(C)佐賀大学医学部附属病院血液・呼吸器・腫瘍内科